Clinical Trial Update: Comparison of the Everolimus Eluting With the Biolimus A9 Eluting Stent [Phase 4]

View source ↗

Summary

Phase 4 trial comparing everolimus-eluting stents with Biolimus A9-eluting stents in coronary artery disease is being updated. Current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Biolimus A9-eluting stent (biolimus A9-eluting stent)
• Everolimus-eluting stent (everolimus-eluting stent)

Snippet

Sponsor: Maasstad Hospital | Conditions: Coronary Artery Disease | Phase 4 | Status: UNKNOWN